companydata.dkcompanydata.dk

OLANDER CLINICAL CONSULTING K/S: Financial statements 2023

CVR: 35860177

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,882,763 and a net result of DKK 1,883,012 compared with DKK 1,880,355 the year before. That is a decrease of 1.9% compared with the year before. Equity in the 2023 report amounted to DKK 621,549. The solvency ratio was 66.6%.

Gross Profit
DKK 1,882,763
Profit/Loss
DKK 1,883,012
Equity
DKK 621,549
Total Assets
DKK 933,500
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-1.9M1.9M622K0
2022-1.9M1.9M621K-
2021-1.8M1.8M687K-
2020-1.5M1.5M461K-
2019-1.4M1.4M491K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

OLANDER CLINICAL CONSULTING K/S: The 2022 annual report is outJun 26, 2023

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2022. Gross profit came to DKK 1,919,291, and the net result was DKK 1,880,355.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity in the 2025 report amounted to DKK 303,261.

Source: annual report 2025, Danish Business Authority